AccueilPodcastsThe Long Run with Luke TimmermanEp209: Mathai Mammen on Developing Drugs Against Undruggable TargetsThe Long Run with Luke TimmermanEp209: Mathai Mammen on Developing Drugs Against Undruggable Targets9 septembre 2026 · 1 h 36 minLire l’épisodePartager à partir d’iciNotes de l’épisodeMathai Mammen, CEO of Cambridge, Mass.-based Parabilis Medicine, on developing alpha helical peptide molecules against hard targets of disease.Tous les épisodes de The Long Run with Luke Timmerman